Data / Research funding / California / Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center: 57 NIH awards ($70.7M), fiscal years 2021 to 2026
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center in Torrance, CA is funded under 57 NIH awards ($70.7M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
Get awards like theseWatch Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
- UEI
- LTJVF4QSFCP9
- State
- California
Awards
57 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Systems Epigenomics of Persistent Bloodstream Infection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $6,975,556 | August 10, 2023 | May 31, 2028 | YEAMAN, MICHAEL R | reporter.nih.gov |
| CCTN - CLINICAL EVALUATION OF NESTORONE GEL AND TESTOSTERONE - SITES FOR MALE CONTRACEPTIVE RESEARCH | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $6,321,144 | September 15, 2015 | December 31, 2025 | WANG, CHRISTINA | reporter.nih.gov |
| Center for Male Reproductive Epigenomics | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $4,344,301 | September 13, 2019 | March 31, 2025 | YAN, WEI | reporter.nih.gov |
| Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,343,171 | January 9, 2019 | December 31, 2024 | IBRAHIM, ASHRAF S. | reporter.nih.gov |
| Transcriptional networks governing A. fumigatus virulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,301,255 | September 22, 2021 | August 31, 2026 | FILLER, SCOTT G | reporter.nih.gov |
| Type I IFN signaling during lung development in Down Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,274,532 | September 17, 2021 | June 30, 2027 | DANOPOULOS, SOULA ATHANASIA | reporter.nih.gov |
| Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,773,800 | February 1, 2006 | June 30, 2027 | IBRAHIM, ASHRAF S. | reporter.nih.gov |
| Novel cardiopulmonary exercise testing variables to differentiate neuromuscular deconditioning from disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,311,759 | September 1, 2023 | August 31, 2028 | ROSSITER, HARRY B | reporter.nih.gov |
| Coronary Artery Calcium, Aortic Calcification and Density in MESA | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,221,188 | April 1, 2020 | March 31, 2025 | BUDOFF, MATTHEW J | reporter.nih.gov |
| Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,205,213 | July 1, 2025 | May 31, 2030 | IBRAHIM, ASHRAF S. | reporter.nih.gov |
| Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,085,900 | July 16, 2018 | June 30, 2025 | MILLER, LOREN G. | reporter.nih.gov |
| Oral commensal fungi and structural immunity | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $2,038,243 | July 1, 2022 | May 31, 2027 | SWIDERGALL, MARC | reporter.nih.gov |
| E-Cigarette Vaping during Pregnancy and Lactation, Germ Cell Epigenetic Memory, and Transgenerational Asthma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,694,775 | June 1, 2020 | May 31, 2025 | REHAN, VIRENDER K | reporter.nih.gov |
| Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,550,702 | September 14, 2020 | May 31, 2025 | ROSS, MICHAEL GLENN | reporter.nih.gov |
| Tryptophan metabolism and its role in fibroid pathogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,537,148 | September 30, 2022 | June 30, 2027 | KHORRAM, OMID A. | reporter.nih.gov |
| Epitranscriptomic regulation of spermatogenesis and male fertility | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,500,383 | September 1, 2020 | April 30, 2026 | YAN, WEI | reporter.nih.gov |
| Mechanism of Long Non-coding RNAs Action in leiomyoma | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,296,607 | September 8, 2020 | June 30, 2025 | KHORRAM, OMID A. | reporter.nih.gov |
| The role of purine biosynthesis and stringent response in persistent MRSA endovascular infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,252,387 | January 14, 2019 | December 31, 2024 | XIONG, YAN Q. | reporter.nih.gov |
| Determinants of 5 Year Progression of Muscle Dysfunction and Inactivity in COPDGene Participants. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,246,331 | February 1, 2020 | January 31, 2025 | ROSSITER, HARRY B | reporter.nih.gov |
| Cellular Senescence in Trisomy 21 lung disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,236,223 | September 1, 2024 | June 30, 2028 | AL ALAM, DENISE | reporter.nih.gov |
| Defining cerebellar pathophysiology in Ataxia Telangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,223,426 | January 15, 2024 | December 31, 2028 | MATHEWS, PAUL JAMES | reporter.nih.gov |
| Spatiotemporal regulation of human islet organogenesis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,203,468 | April 1, 2024 | February 28, 2029 | YOSHIHARA, EIJI | reporter.nih.gov |
| Bicarbonate-Mediated Enhancement of Beta-Lactam-MRSA Killing: Mechanisms and Clinical Translatability | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,093,842 | June 1, 2019 | May 31, 2024 | XIONG, YAN Q. | reporter.nih.gov |
| Mechanisms controlling early human lung development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $972,953 | August 1, 2018 | May 31, 2024 | AL-ALAM, DENISE | reporter.nih.gov |
| BRAIN (Biomimetic Regenerative Angiogenic Immunomodulating Nanocomposite) materials for brain repair after stroke | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2023 | $936,719 | January 1, 2022 | December 31, 2026 | NIH, LINA R. | reporter.nih.gov |
| Deciphering functions of the ATR-METTL3-BRCA1 Axis in genome instability and Tumorigenesis | NIH | National Cancer Institute | 2024 to 2025 | $920,030 | June 1, 2024 | May 31, 2026 | WANG, HUA | reporter.nih.gov |
| Plant-Focused Nutrition in Patients with Diabetes and Chronic Kidney Disease (PLAFOND Study): A Pilot/Feasibility Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $836,447 | July 10, 2023 | May 31, 2027 | KALANTAR-ZADEH, KAMYAR | reporter.nih.gov |
| Mechanisms and Circumvention of Daptomycin Resistance in Streptococcus mitis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $791,490 | November 15, 2017 | October 31, 2023 | BAYER, ARNOLD S | reporter.nih.gov |
| Targeting the regulatory mechanism of hyphae to lateral yeast growth as a novel therapeutic approach against candidiasis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $746,320 | August 9, 2019 | July 31, 2024 | UPPULURI, PRIYA | reporter.nih.gov |
| Sleep loss and circadian misalignment - mechanisms of Insulin Resistance | NIH | National Heart, Lung, and Blood Institute | 2025 | $743,388 | August 15, 2025 | May 31, 2029 | LIU, PETER YIWEN | reporter.nih.gov |
| Pulmonary neuroimmune determinants of immunoglobulin production against pneumonia | NIH | National Heart, Lung, and Blood Institute | 2025 | $718,661 | August 1, 2025 | April 30, 2030 | JENDZJOWSKY, NICHOLAS | reporter.nih.gov |
| A Type 2 Hybrid Effectiveness-Implementation Study of Time Limited Trials to Reduce Potentially Non-Beneficial Treatments for Critically Ill Patients with Advanced Medical Illnesses | NIH | National Institute on Aging | 2025 | $632,507 | September 25, 2025 | August 31, 2030 | CHANG, DONG WOOK | reporter.nih.gov |
| C. albicans invasion and proliferation during oral infection | NIH | National Institute of Dental & Craniofacial Research | 2021 | $539,989 | April 1, 2017 | March 31, 2023 | FILLER, SCOTT G | reporter.nih.gov |
| Optimizing Small Molecule Read-Through Compounds for Treating AtaxiaTelangiectasia | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $508,727 | April 19, 2022 | October 31, 2024 | MATHEWS, PAUL JAMES | reporter.nih.gov |
| Type I interferon regulates angiogenesis in Down Syndrome Supplement | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $507,399 | September 6, 2022 | January 31, 2025 | AL-ALAM, DENISE | reporter.nih.gov |
| Targeting evolutionarily acquired insertion sequences in Candida species, for development of antifungal drugs | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $457,900 | November 18, 2022 | October 31, 2024 | UPPULURI, PRIYA | reporter.nih.gov |
| Suicidal Behavior among Adolescents Experiencing Homelessness in the US during the COVID-19 Pandemic | NIH | National Institute of Mental Health | 2024 to 2025 | $453,341 | August 1, 2024 | July 31, 2026 | SAKAI-BIZMARK, RIE | reporter.nih.gov |
| Behavioral and brain network effects of dysfunction in the cognitive cerebellum | NIH | National Institute of Mental Health | 2022 to 2023 | $453,179 | July 1, 2022 | June 30, 2025 | MATHEWS, PAUL JAMES | reporter.nih.gov |
| Delineating host response to central venous catheter associated Candida albicans biofilm infections, and development of novel therapeutics to combat drug resistant biofilms | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $451,639 | March 7, 2024 | January 31, 2026 | UPPULURI, PRIYA | reporter.nih.gov |
| IND-enabling studies to develop triptonide into the first nonhormonal male pill | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $439,094 | February 1, 2024 | February 2, 2025 | YAN, WEI | reporter.nih.gov |
| Unraveling transcriptomic and functional changes to immune sensing neuronal ganglia in response to allergy and bacteria | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $438,308 | May 6, 2022 | April 30, 2024 | JENDZJOWSKY, NICHOLAS | reporter.nih.gov |
| Prevention of obesity in Infants of overweight and obese women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $423,775 | June 1, 2021 | August 31, 2024 | ROSS, MICHAEL GLENN | reporter.nih.gov |
| Disparities in the effect of state policy for the newborn screening for critical congenital heart diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $423,775 | September 23, 2021 | August 31, 2024 | SAKAI-BIZMARK, RIE | reporter.nih.gov |
| Asthmatic inflammation requires neuronal upregulation of B-cells | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $332,000 | March 5, 2024 | February 28, 2025 | JENDZJOWSKY, NICHOLAS | reporter.nih.gov |
| Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $275,156 | June 1, 2018 | May 31, 2024 | SAKAI-BIZMARK, RIE | reporter.nih.gov |
| Role of multi-drug resistant Candida auris Hyr1 / Iff-like proteins in virulence and their potential as vaccine targets | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $269,800 | July 18, 2024 | June 30, 2029 | SINGH, SHAKTI | reporter.nih.gov |
| Mouse model of neonatal fungal colonization to study homeostasis and disease | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $245,250 | July 14, 2025 | June 30, 2027 | SWIDERGALL, MARC | reporter.nih.gov |
| Mentorship in the Endocrinology of Sleep | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $239,172 | May 1, 2018 | April 30, 2024 | LIU, PETER YIWEN | reporter.nih.gov |
| Novel Candida albicans host receptors during infection and immune response | NIH | National Institute of Dental & Craniofacial Research | 2021 | $236,711 | September 1, 2019 | August 31, 2022 | SWIDERGALL, MARC | reporter.nih.gov |
| CCTN-CORE FUNCTION ACTIVITIES - SITE OF MALE CONTRACEPTIVE STUDIES - UCLA-LUNDQUIST | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $197,188 | September 28, 2020 | September 27, 2026 | SWERDLOFF, RON | reporter.nih.gov |
| Exploring the role of Hedgehog pathway-Primary cilia axis in human lung alveologenesis and disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $156,168 | August 1, 2025 | July 31, 2027 | BELGACEMI, RANDA SONIA | reporter.nih.gov |
| Function of Long Non-Coding RNA MD1 in Leiomyoma Pathogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $154,100 | March 15, 2021 | February 29, 2024 | KHORRAM, OMID A. | reporter.nih.gov |
| BRC Modernization of Sterilizing Equipment | NIH | Office of the Director, National Institutes of Health | 2024 | $128,500 | August 15, 2024 | August 14, 2025 | GUERRA, CATALINA MARIA | reporter.nih.gov |
| Examining the Androgenic and Progestational Effects of Novel Androgens for Male Contraception | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $38,571 | September 4, 2021 | March 3, 2022 | YUEN, FIONA N | reporter.nih.gov |
| US DOHaD Society: The 5th Annual Meeting 2020 | NIH | National Institute of Environmental Health Sciences | 2021 | $13,000 | March 1, 2021 | February 28, 2022 | DESAI, MINA | reporter.nih.gov |
| The XXVIth North American Testis Workshop | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $10,000 | April 1, 2022 | March 31, 2023 | YAN, WEI | reporter.nih.gov |
| Celebrating the Inspired and Inspiring Testis Biology- The XXVII North American Testis Workshop | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $10,000 | April 1, 2024 | March 31, 2025 | YAN, WEI | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 23 | $13,663,280 | 0 | $0 |
| 2024 | 24 | $12,270,474 | 0 | $0 |
| 2023 | 24 | $16,100,630 | 0 | $0 |
| 2022 | 32 | $15,862,215 | 0 | $0 |
| 2021 | 27 | $12,836,012 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) | PA-24-194 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 16 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 16 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 16 awards here |
Topics of its NIH awards
- Prevention
- Genetics
- Clinical Research
- Infectious Diseases
- Lung
- Pediatric
- Neurosciences
- Contraception/Reproduction
- Biotechnology
- Behavioral and Social Science
- Clinical Trials and Supportive Activities
- Women's Health
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.